GLENMEDE TRUST CO NA - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 201 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,757,197
+15.3%
1,324,735
+26.0%
0.07%
+15.9%
Q2 2023$11,064,703
+0.3%
1,051,046
+0.2%
0.06%0.0%
Q1 2023$11,035,616
-14.2%
1,049,013
+1.1%
0.06%
-16.0%
Q4 2022$12,856,681
+6.5%
1,037,666
-10.9%
0.08%
-1.3%
Q3 2022$12,071,000
-19.8%
1,165,208
-10.7%
0.08%
-13.6%
Q2 2022$15,045,000
-17.3%
1,304,913
-9.8%
0.09%
-1.1%
Q1 2022$18,201,000
+44.6%
1,446,899
+34.0%
0.09%
+48.3%
Q4 2021$12,589,000
-11.8%
1,079,826
-1.2%
0.06%
-18.9%
Q3 2021$14,269,000
+1.0%
1,092,610
-0.5%
0.07%
+1.4%
Q2 2021$14,127,000
+14.9%
1,097,813
-0.2%
0.07%
+10.6%
Q1 2021$12,300,000
+33.1%
1,100,301
+35.6%
0.07%
+29.4%
Q4 2020$9,241,000
+14.2%
811,463
-9.8%
0.05%
+6.2%
Q3 2020$8,094,000
+40370.0%
899,965
+44277.0%
0.05%
Q2 2020$20,000
-23.1%
2,0280.0%0.00%
Q1 2020$26,0000.0%2,0280.0%0.00%
Q4 2019$26,000
+52.9%
2,0280.0%0.00%
Q3 2019$17,000
-22.7%
2,0280.0%0.00%
Q2 2019$22,000
-18.5%
2,0280.0%0.00%
Q1 2019$27,000
+28.6%
2,028
-1.4%
0.00%
Q4 2018$21,000
-43.2%
2,057
+1.4%
0.00%
Q3 2018$37,000
-5.1%
2,0290.0%0.00%
Q2 2018$39,000
+25.8%
2,029
-3.8%
0.00%
Q1 2018$31,0000.0%2,1100.0%0.00%
Q4 2017$31,000
-6.1%
2,1100.0%0.00%
Q3 2017$33,000
-5.7%
2,1100.0%0.00%
Q2 2017$35,0000.0%2,1100.0%0.00%
Q1 2017$35,000
+9.4%
2,1100.0%0.00%
Q4 2016$32,000
-5.9%
2,110
-4.1%
0.00%
Q3 2016$34,000
+25.9%
2,200
+4.3%
0.00%
Q2 2016$27,000
+17.4%
2,1100.0%0.00%
Q1 2016$23,0000.0%2,110
+5.5%
0.00%
Q4 2015$23,000
+15.0%
2,0000.0%0.00%
Q3 2015$20,000
-16.7%
2,0000.0%0.00%
Q2 2015$24,000
-25.0%
2,0000.0%0.00%
Q1 2015$32,000
+6.7%
2,0000.0%0.00%
Q4 2014$30,000
+20.0%
2,0000.0%0.00%
Q3 2014$25,000
-16.7%
2,0000.0%0.00%
Q2 2014$30,000
+25.0%
2,0000.0%0.00%
Q1 2014$24,000
+4.3%
2,0000.0%0.00%
Q4 2013$23,0000.0%2,0000.0%0.00%
Q3 2013$23,000
+21.1%
2,0000.0%0.00%
Q2 2013$19,0002,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders